[
  {
    "ts": null,
    "headline": "Vertex to Announce Second Quarter 2025 Financial Results on August 4th",
    "summary": "BOSTON, July 08, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \"Vertex Pharmaceuticals Second Quarter 2025 Earnings Call.\"",
    "url": "https://finnhub.io/api/news?id=d8e49cad8d89a0a91dd65c53bbd6341f4bd1a1c4a9a971b9ed8359cdfa1dfbc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752004800,
      "headline": "Vertex to Announce Second Quarter 2025 Financial Results on August 4th",
      "id": 135826836,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BOSTON, July 08, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2025 financial results on Monday, August 4, 2025 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \"Vertex Pharmaceuticals Second Quarter 2025 Earnings Call.\"",
      "url": "https://finnhub.io/api/news?id=d8e49cad8d89a0a91dd65c53bbd6341f4bd1a1c4a9a971b9ed8359cdfa1dfbc5"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=16d97b3857fededf798ed297c839232d1dbef0265fa6c8fe0cbd07f74e6df1c0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751992680,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 135861140,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=16d97b3857fededf798ed297c839232d1dbef0265fa6c8fe0cbd07f74e6df1c0"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2",
    "summary": "Vertex Protocol, a leading decentralized exchange platform known for its high-performance trading architecture and active community, has entered an agreement with the Ink Foundation to bring its core infrastructure and team to the Ink ecosystem. The move marks a major milestone for the Ink Layer 2's growing DeFi stack.",
    "url": "https://finnhub.io/api/news?id=e752a0fb5d7a5ab2101cb82df59e44841a7db3a83a26c86ced9e81d0386eca81",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751983200,
      "headline": "Vertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2",
      "id": 135806350,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Protocol, a leading decentralized exchange platform known for its high-performance trading architecture and active community, has entered an agreement with the Ink Foundation to bring its core infrastructure and team to the Ink ecosystem. The move marks a major milestone for the Ink Layer 2's growing DeFi stack.",
      "url": "https://finnhub.io/api/news?id=e752a0fb5d7a5ab2101cb82df59e44841a7db3a83a26c86ced9e81d0386eca81"
    }
  },
  {
    "ts": null,
    "headline": "Do You Believe in the Upside Potential of Vertex Pharmaceuticals (VRTX)?",
    "summary": "PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, outperforming the S&P 500’s -4.3% return. Biotechnology and healthcare providers and services surpassed the Index in performance during this quarter. Pharmaceuticals, healthcare […]",
    "url": "https://finnhub.io/api/news?id=0fce670b5fee5d2c568fa72b37cf74aa001254ef8e2fd3192d624aba4ddbfe16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751976959,
      "headline": "Do You Believe in the Upside Potential of Vertex Pharmaceuticals (VRTX)?",
      "id": 135806351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, outperforming the S&P 500’s -4.3% return. Biotechnology and healthcare providers and services surpassed the Index in performance during this quarter. Pharmaceuticals, healthcare […]",
      "url": "https://finnhub.io/api/news?id=0fce670b5fee5d2c568fa72b37cf74aa001254ef8e2fd3192d624aba4ddbfe16"
    }
  }
]